Patents/Assignees

MEDIPOST CO., Ltd

1 patent in portfolio

US12303534utility2025
Pharmaceutical Composition Comprising Mesenchymal Stem Cells as Effective Ingredient for Prevention or Treatment of Inflammatory Disease
0 cites